Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Moving Up the Coagulation Cascade: Potential Factor X Inhibition for Percutaneous Coronary Intervention.

Richard C. Becker1, Frederick A. Spencer

  • 1Cardiovascular Thrombosis Research Center and Anticoagulation Services, University of Massachusetts-Memorial Medical Center, 55 Lake Avenue, North Worcester, MA 01655, USA. beckerr@ummhc.org

Current Interventional Cardiology Reports
|August 4, 2001
PubMed
Summary

Targeting factor X, an early step in blood coagulation, offers a new strategy to prevent arterial thrombosis after procedures like percutaneous coronary interventions, moving beyond older "final common pathway" concepts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Myocardial Infarction: Antithrombotic Therapy.

Current treatment options in cardiovascular medicineยท2003
See all related articles

Area of Science:

  • Vascular biology
  • Hemostasis and thrombosis
  • Pharmacology

Background:

  • Recent shifts in platelet biology research challenge established
  • final common pathway
  • concepts.

Purpose of the Study:

  • To explore pharmacologic strategies targeting earlier steps in vascular coagulation.
  • To identify novel therapeutic targets for arterial thrombosis.

Main Methods:

  • Investigating the inhibition of early bioamplification sequences in coagulation.
  • Focusing on the neutralization of coagulation factor X.

Main Results:

  • Inhibiting early reactions minimizes downstream substrate production.
  • Factor X neutralization is a key target in thrombin generation.

Related Experiment Videos

Conclusions:

  • Neutralizing factor X is a promising approach for arterial thrombosis.
  • This strategy is particularly relevant after percutaneous coronary interventions involving vessel trauma.